Related Experiment Video
Updated: Jul 12, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity
Katharine Orf1,2, Hannah Al Yousuf2, Thomas A Fox1,2
1Institute of Immunity & Transplantation, University College London, London, UK.
Insights
Early referral for adult Inborn Errors of Immunity (IEI) patients undergoing allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is crucial. Patients deemed too high-risk for HSCT face significantly poorer survival rates.
Area of Science:
- Immunology
- Hematology
- Transplantation Medicine
Background:
- Inborn Errors of Immunity (IEI) are a group of rare genetic disorders affecting the immune system.
- Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) is a potentially curative treatment for severe IEI.
- International Multidisciplinary Team (MDT) assessment is often employed for complex cases.
Abstract:
Outcomes following international MDT assessment of adult IEI patients for allogeneic HSCT suggest early referral is vital: patients considered too high risk for transplant have poor outcomes with a 3-year overall survival of 31%.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Regulation of Hematopoietic Stem Cells
